IFNB1 and inflammatory bowel disease: In addition, the researchers found that variants in TRIM22 influenced the activation of NOD2-dependent IFN-β signaling and the upregulation of NF-κB pathways in early-onset inflammatory bowel disease, and the TRIM22-NOD2 network affected antiviral pathways leading to inflammation [53].